Target intelligence / Profile preview

Adenylate kinase 1 (AK1)

Target
AK1
Molecular classification
Enzyme, Nucleoside monophosphate kinase family
01

Overview

Adenylate kinase 1 (AK1) is an essential enzyme responsible for catalyzing the reversible transfer of phosphate groups between ATP and AMP, maintaining energy homeostasis by regulating adenine nucleotide ratios in cells[3][6]. It is highly expressed in tissues with high energy demand, such as skeletal muscle, brain, and red blood cells[3]. AK1 is critical for cellular energy metabolism, and mutations in the AK1 gene can cause a rare form of nonspherocytic hemolytic anemia in humans[3]. The protein functions as a monomer and consists of several domains involved in binding ATP, AMP, and phosphate transfer[1][2]. Although not widely targeted by approved drugs, its structural and functional properties make it a potential target for drug discovery related to energy metabolism and inherited metabolic disorders[4][6].

Other names
AK-1adenylate kinase isoenzyme 1
02

Mechanism of action

Catalyzes the reversible transfer of a phosphate group between ATP and AMP (ATP + AMP ↔ 2 ADP), thereby regulating energy state in the cell[3][6]

03

Biological functions

Cellular energy metabolismhomeostasis of adenine nucleotide ratiosregulation of ATP, ADP and AMP balancesignal transduction
04

Disease associations

Hemolytic anemiametabolic disorderspossibly cancer and other diseases linked to impaired energy metabolism
05

Safety considerations

Genetic deficiency causes hemolytic anemia; targeting may interfere with essential cellular energy balance[3]
06

Interacting drugs

No major approved interacting drugs identified; enzyme activity can be probed by small molecule ligands in research settings[4]
07

Biomarkers

Mutations or reduced activity may serve as biomarkers for nonspherocytic hemolytic anemia[3]

Beyond the preview

Go deeper on Adenylate kinase 1 (AK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenylate kinase 1 (AK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call